Long-term consumption of caffeine improves glucose homeostasis by enhancing insulinotropic action through islet insulin/insulin-like growth factor 1 signaling in diabetic rats

Metabolism: Clinical and Experimental

Volumn 56, Issue 5, 2007, Pages 599-607

  Park, Sunmin ^a   Jang, Jin Sun ^a   Hong, Sang Mee ^a  

^a Institute of Basic Sciences   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; INSULIN; SOMATOMEDIN C; SUCROSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY FAT; CELL FUNCTION; CONTROLLED STUDY; DISEASE EXACERBATION; FOOD INTAKE; GLUCOSE HOMEOSTASIS; INSULIN SENSITIVITY; MALE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; WEIGHT REDUCTION;

ANIMALS; BLOOD GLUCOSE; CAFFEINE; DIABETES MELLITUS, TYPE 2; GLUCOKINASE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TRANSPORTER TYPE 2; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; INSULIN-SECRETING CELLS; MALE; PANCREATECTOMY; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SECRETORY RATE; SIGNAL TRANSDUCTION; SUCROSE;

EID: 34147094089     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2006.12.004     Document Type: Article

References (34)

1. DeFronzo R.A., Bonadonna R.C., and Ferrannini E. Pathogenesis of NIDDM: a balanced overview. Diabetes Care 15 (1992) 318-353
2. Cockram C.S. The epidemiology of diabetes mellitus in the Asia-Pacific region. Hong Kong Med J 6 (2000) 43-52
3. The expert panel in Korean Medical Insurance Association. 1992 annuals for medical insurance statistics (1995), Ministry of Health and Welfare, Seoul
4. The Division of National Nutrition Survey. 1993 national nutrition survey report in Korea (1996), Ministry of Health and Welfare, Seoul
5. Min H.K. Non-insulin-dependent diabetes mellitus (NIDDM) in Korea. Diabet Med 13 (1996) S13-S15
6. Park S., Park C.H., and Choi S.B. Effect of cola intake on insulin resistance in moderate fat-fed weaning male rats. J Nutr Biochem 13 (2002) 727-733
7. Keijzers G.B., De Galan B.E., Tack C.J., and Smits P. Caffeine can decrease insulin sensitivity in humans. Diabetes Care 25 (2002) 364-369
8. Lee S., Hudson R., Kilpatrick K., Graham T.E., and Ross R. Caffeine ingestion is associated with reductions in glucose uptake independent of obesity and type 2 diabetes before and after exercise training. Diabetes Care 28 (2005) 566-572
9. Robinson L.E., Savani S., Battram D.S., McLaren D.H., Sathasivam P., and Graham T.E. Caffeine ingestion before an oral glucose tolerance test impairs blood glucose management in men with type 2 diabetes. J Nutr 134 (2004) 2528-2533
10. Salazar-Martinez E., Willett W.C., Ascherio A., et al. Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med 140 (2004) 1-8
11. van Dam R.M., and Feskens E.J. Coffee consumption and risk of type 2 diabetes mellitus. Lancet 360 (2002) 1477-1478
12. Knowler W.C., Pettitt D.J., Saad M.F., and Bennett P.H. Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis. Diabetes Metab Rev 6 (1990) 1-27
13. Lopez-Garcia E., van Dam R.M., Willett W.C., et al. Coffee consumption and coronary heart disease in men and women: a prospective cohort study. Circulation 113 (2006) 2045-2053
14. Hosokawa Y.A., Hosokawa H., Chen C., and Leahy J.L. Mechanism of impaired glucose-potentiated insulin-secretion in diabetic 90 percent pancreatectomy rats-study using glucagon-like peptide-1 (7-37). J Clin Invest 97 (1996) 180-186
15. Committee of the American Institute of Nutrition. Ad hoc committee on standards for nutritional studies. J Nutr 107 (1997) 1340-1348
16. Dobbins R.L., Szczepaniak L.S., Myhill J., et al. The composition of dietary fat directly influences glucose-stimulated insulin secretion in rats. Diabetes 51 (2002) 1825-1833
17. Choi S.B., and Park S. Does fluoxetine administration influence insulin resistance in 90% pancreatectomized rats?. Metabolism 51 (2002) 38-43
18. Oddeti P.R., Borgrglio A., Pascal A.D., Rolandi R., and Adezati L. Prevention of diabetes-increased aging effect on rat collagen linked fluorescence by aminoguanine and rutin. Diabetes 39 (1990) 796-802
19. Hennige A.M., Burks D.J., Ozcan U., et al. Upregulation of insulin receptor substrate-2 in pancreatic beta cells prevents diabetes. J Clin Invest 112 (2003) 1521-1532
20. Choi S.B., Jang J.S., and Park S. Estrogen and exercise may enhance beta-cell function and mass via IRS2 induction in ovariectomized diabetic rats. Endocrinology 146 (2005) 4786-4794
21. Rooman I., Lardon J., and Bouwen L. Gastrin stimulates β-cell neogenesis and increases islet mass from transdifferentiated but not from normal exocrine pancreas tissue. Diabetes 51 (2002) 686-690
22. Withers D.J., Burks D.J., Towery H.H., et al. Irs-2 coordinates Igf-1 receptor-mediated beta-cell development and peripheral insulin signaling. Nat Genet 23 (1999) 32-40
23. Park S., Dong X., Fisher T.L., et al. Exendin-4 promotes IRS2 signaling to mediate pancreatic beta-cell growth and function. J Biol Chem 281 (2005) 1159-1168
24. Committee of SAS Institute. Guide for personal computers (1985), SAS Institutes Inc, Cary 257-260
25. Otani K., Kulkarni R.N., Baldwin A.C., et al. Reduced beta-cell mass and altered glucose sensing impair insulin-secretory function in betaIRKO mice. Am J Physiol Endocrinol Metab 286 (2004) E41-E49
26. Weir G.C., and Bonner-Weir S. Five stages of evolving β-cell dysfunction during progression to diabetes. Diabetes 53 (2004) S16-S21
27. van Dam R.M., and Hu F.B. Coffee consumption and risk of type 2 diabetes: a systematic review. JAMA 294 (2005) 97-104
28. Canettieri G., Koo S.H., Berdeaux R., et al. Dual role of the coactivator TORC2 in modulating hepatic glucose output and insulin signaling. Cell Metab 2 (2005) 331-338
29. Jhala U.S., Canettieri G., Screaton R.A., et al. cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2. Genes Dev 17 (2003) 1575-1580
30. Kuehn B.M. New diabetes drugs target gut hormones. JAMA 296 (2006) 380-381
31. Zhang X., Gan L., Pan H., et al. Phosphorylation of serine 256 suppresses transactivation by FKHR (FOXO1) by multiple mechanisms. J Biol Chem 277 (2002) 45276-45284
32. Tamemoto H., Kadowaki T., Tobe K., et al. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 372 (1994) 182-186
33. Withers D.J., Gutierrez J.S., Towery H., et al. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391 (1998) 900-904
34. Jetton T.L., Lausier J., LaRock K., et al. Mechanisms of compensatory beta-cell growth in insulin-resistant rats: roles of Akt kinase. Diabetes 54 (2005) 2294-2304